Glenner, G. G. & Wong, C. W. Alzheimers disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885890 (1984).

Article CAS PubMed Google Scholar

van Dyck, C. H. et al. Lecanemab in early Alzheimers disease. N. Engl. J. Med. 388, 921 (2023).

Article PubMed Google Scholar

Mintun, M. A. et al. Donanemab in early Alzheimers disease. N. Engl. J. Med. 384, 16911704 (2021).

Article CAS PubMed Google Scholar

Serrano-Pozo, A., Aldridge, G. M. & Zhang, Q. Four decades of research in Alzheimers disease (19752014): a bibliometric and scientometric analysis. J. Alzheimers Dis. 59, 763783 (2017).

Article PubMed PubMed Central Google Scholar

Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimers disease in late onset families. Science 261, 921923 (1993).

Article CAS PubMed Google Scholar

Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 13491356 (1997).

Article CAS PubMed Google Scholar

Corder, E. H. et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7, 180184 (1994).

Article CAS PubMed Google Scholar

Reiman, E. M. et al. Exceptionally low likelihood of Alzheimers dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat. Commun. 11, 667 (2020).

Article CAS PubMed PubMed Central Google Scholar

Mattsson, N. et al. Prevalence of the apolipoprotein E 4 allele in amyloid positive subjects across the spectrum of Alzheimers disease. Alzheimers Dement. 14, 913924 (2018).

Article PubMed Google Scholar

Belloy, M. E. et al. APOE genotype and Alzheimer disease risk across age, sex, and population ancestry. JAMA Neurol. 80, 12841294 (2023).

Article PubMed PubMed Central Google Scholar

Granot-Hershkovitz, E. et al. APOE alleles association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos investigation of neurocognitive aging (HCHS/SOL). Alzheimers Dement. 17, 466474 (2021).

Article CAS PubMed Google Scholar

Rajabli, F. et al. Ancestral origin of ApoE 4 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet. 14, e1007791 (2018).

Article PubMed PubMed Central Google Scholar

Blue, E. E., Horimoto, A. R. V. R., Mukherjee, S., Wijsman, E. M. & Thornton, T. A. Local ancestry at APOE modifies Alzheimers disease risk in Caribbean Hispanics. Alzheimers Dement. 15, 15241532 (2019).

Article PubMed Google Scholar

Griswold, A. J. et al. Increased APOE 4 expression is associated with the difference in Alzheimers disease risk from diverse ancestral backgrounds. Alzheimers Dement. 17, 11791188 (2021).

Article CAS PubMed Google Scholar

Nuytemans, K. et al. Identifying differential regulatory control of APOE 4 on African versus European haplotypes as potential therapeutic targets. Alzheimers Dement. 18, 19301942 (2022).

Article CAS PubMed Google Scholar

Fortea, J. et al. APOE4 homozygosity represents a distinct genetic form of Alzheimers disease. Nat. Med. 30, 12841291 (2024).

Article CAS PubMed Google Scholar

Qian, J. et al. APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts. PLoS Med. 14, e1002254 (2017).

Article PubMed PubMed Central Google Scholar

Stites, S. D. et al. Patients asking about APOE gene test results? Heres what to tell them. J. Fam. Pract. 71, E1E7 (2022).

PubMed PubMed Central Google Scholar

Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimers disease. Nat. Genet. 53, 12761282 (2021).

Article CAS PubMed PubMed Central Google Scholar

Bellenguez, C. et al. New insights into the genetic etiology of Alzheimers disease and related dementias. Nat. Genet. 54, 412436 (2022).

Article CAS PubMed PubMed Central Google Scholar

Huq, A. J. et al. Polygenic score modifies risk for Alzheimers disease in APOE 4 homozygotes at phenotypic extremes. Alzheimers Dement. 13, e12226 (2021).

Google Scholar

Ebenau, J. L. et al. Risk of dementia in APOE 4 carriers is mitigated by a polygenic risk score. Alzheimers Dement. 13, e12229 (2021).

Google Scholar

Erickson, C. M. et al. KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD. Neurology 92, e1878e1889 (2019).

Article CAS PubMed PubMed Central Google Scholar

Belloy, M. E. et al. Association of klotho vs heterozygosity with risk of Alzheimer disease in individuals who carry APOE4. JAMA Neurol. 77, 849862 (2020).

Article PubMed PubMed Central Google Scholar

Neitzel, J. et al. KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimers disease. Nat. Commun. 12, 3825 (2021).

Article CAS PubMed PubMed Central Google Scholar

Ali, M. et al. Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of klotho heterozygosity on disease risk. PLoS ONE 17, e0267298 (2022).

Article CAS PubMed PubMed Central Google Scholar

Huq, A. J. et al. Genetic resilience to Alzheimers disease in APOE 4 homozygotes: a systematic review. Alzheimers Dement. 15, 16121623 (2019).

Article PubMed Google Scholar

Serrano-Pozo, A. & Growdon, J. H. Is Alzheimers disease risk modifiable? J. Alzheimers Dis. 67, 795819 (2019).

Article PubMed PubMed Central Google Scholar

Jaisa-Aad, M., Muoz-Castro, C. & Serrano-Pozo, A. Update on modifiable risk factors for Alzheimers disease and related dementias. Curr. Opin. Neurol. 37, 166181 (2024).

Article PubMed Google Scholar

Kolli, A. et al. Interactions between the apolipoprotein E4 gene and modifiable risk factors for cognitive impairment: a nationally representative panel study. BMC Geriatr. 22, 938 (2022).

Article CAS PubMed PubMed Central Google Scholar

Langella, S. et al. Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimers disease. Nat. Commun. 14, 5120 (2023).

Article CAS PubMed PubMed Central Google Scholar

Park, S.-Y. et al. Modifying effects of race and ethnicity and APOE on the association of physical activity with risk of Alzheimers disease and related dementias. Alzheimers Dement. 19, 507517 (2023).

Article CAS PubMed Google Scholar

Jia, J. et al. Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study. Br. Med. J. 380, e072691 (2023).

Article Google Scholar

Park, S.-Y. et al. Racial and ethnic differences in the population-attributable fractions of Alzheimer disease and related dementias. Neurology 102, e208116 (2024).

Article PubMed Google Scholar

Lee, M. et al. Variation in population attributable fraction of dementia associated with potentially modifiable risk factors by race and ethnicity in the US. JAMA Netw. Open 5, e2219672 (2022).

Article PubMed PubMed Central Google Scholar

Arboleda-Velasquez, J. F. et al. Resistance to autosomal dominant Alzheimers disease in an APOE3 Christchurch homozygote: a case report. Nat. Med. 25, 16801683 (2019).

Article CAS PubMed PubMed Central Google Scholar

He, K. Y. et al. Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants. Mol. Neurodegener. 18, 92 (2023).

Article PubMed PubMed Central Google Scholar

Wardell, M. R., Brennan, S. O., Janus, E. D., Fraser, R. & Carrell, R. W. Apolipoprotein E2-Christchurch (136 ArgSer). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. J. Clin. Invest. 80, 483490 (1987).

Article CAS PubMed PubMed Central Google Scholar

Pocovi, M. et al. Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136Ser) variant in multigenerational pedigree studies. Atherosclerosis 122, 3346 (1996).

Article CAS PubMed Google Scholar

Hernandez, I. et al. Heterozygous APOE Christchurch in familial Alzheimers disease without mutations in other Mendelian genes. Neuropathol. Appl. Neurobiol. 47, 579582 (2021).

Article CAS PubMed Google Scholar

Le Guen, Y. et al. Association of African ancestry-specific APOE missense variant r145c with risk of Alzheimer disease. JAMA 329, 551560 (2023).

Article PubMed PubMed Central Google Scholar

Medway, C. W. et al. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimers disease. Mol. Neurodegener. 9, 11 (2014).

Article PubMed PubMed Central Google Scholar

Le Guen, Y. et al. Association of rare APOE missense variants V236E and R251G with risk of Alzheimer disease. JAMA Neurol. 79, 652663 (2022).

Article PubMed PubMed Central Google Scholar

Liu, C.-C. et al. APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. Sci. Transl. Med. 13, eabc9375 (2021).

Article CAS PubMed PubMed Central Google Scholar

Boyle, P. A. et al. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann. Neurol. 83, 7483 (2018).

Article CAS PubMed PubMed Central Google Scholar

Bennett, D. A. et al. Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people. J. Neurol. Neurosurg. Psychiatry 76, 11941199 (2005).

Article CAS PubMed PubMed Central Google Scholar

Mungas, D., Tractenberg, R., Schneider, J. A., Crane, P. K. & Bennett, D. A. A 2-process model for neuropathology of Alzheimers disease. Neurobiol. Aging 35, 301308 (2014).

Article CAS PubMed Google Scholar

Serrano-Pozo, A., Qian, J., Monsell, S. E., Betensky, R. A. & Hyman, B. T. APOE2 is associated with milder clinical and pathological Alzheimer disease. Ann. Neurol. 77, 917929 (2015).

Article CAS PubMed PubMed Central Google Scholar

Goldberg, T. E., Huey, E. D. & Devanand, D. P. Association of APOE 2 genotype with Alzheimers and non-Alzheimers neurodegenerative pathologies. Nat. Commun. 11, 4727 (2020).

Article CAS PubMed PubMed Central Google Scholar

Goldberg, T. E., Huey, E. D. & Devanand, D. P. Associations of APOE 2 genotype with cerebrovascular pathology: a postmortem study of 1275 brains. J. Neurol. Neurosurg. Psychiatry https://doi.org/10.1136/jnnp-2020-323746 (2020).

Yu, L. et al. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol. Aging 36, 29462953 (2015).

Follow this link:

Multifaceted roles of APOE in Alzheimer disease - Nature.com